Non‑Small Cell Lung Cancer | Emerging Role of Antibody‑Drug Conjugates in the Management of Non‑Small Cell Lung Cancer

Research To Practice | Oncology Videos · Dec 16, 2022 · 59m

Featuring perspectives from Drs Alexander Spira and Helena Yu, including the following topics:

Introduction

What is an antibody-drug conjugate? (0:00)

"HER2-Positive" Non-Small Cell Lung Cancer (NSCLC)

Case: A woman in her mid 50s with HER2 insertion in exon 20 — Dr Yu (8:42)

Targeting HER3 in NSCLC

Case: A man in his early 60s with lung cancer with an EGFR mutation — Dr Yu (25:23)

TROP2-Directed Treatment

Case: A woman in her early 50s with lung cancer with a KRAS G12V mutation — Dr Spira (36:57)

Case: A woman in her mid 60s with metastatic NSCLC and an EGFR exon 19 deletion — Dr Spira…